needed effects
pyrazinamide
unwanted side effects
medical attention
following side effects
taking pyrazinamide
check
doctor
pyrazinamide side effects
medical attention
body
medicine
side effects
health care professional
side effects
following side effects
cardiovascular
side effects
case of acute hypertension
pulmonary tuberculosis
blood pressure
bp
mm hg
acute hypertension
pyrazinamide therapy
combination tablet
containing mg of rifampin
mg of isoniazid
mg pyrazinamide
first dose
episode of intense headache
tachycardia
hours
hospital
physical exam
supine bp
mm hg
pulse of beats per minute
antihypertensive therapy
bp
baseline
mm hg
rechallenge with the individual drugs
mg of pyrazinamide
acute hypertension
mm hg after minutes
year-old male experienced pyrazinamide-induced granulomatous hepatitis
pyrazinamide therapy
hectic fever
chills
extreme fatigue
liver damage
hyperuricemia about weeks
initiating pyrazinamide
mg
times
day
therapy for a positive tuberculin skin test
liver biopsy specimen
noncaseating epithelioid granulomas
patient
discontinuation of pyrazinamide therapy
hepatic side effects
elevation of liver function tests
jaundice
nausea
vomiting
malaise
hepatotoxicity
therapy
case of pyrazinamide-induced granulomatous hepatitis
metabolic side effects
increases in uric acid
inhibition of uric acid
renal secretion
metabolic reaction
development of gout
changes in blood glucose
hematologic side effects
thrombocytopenia with purpuric lesions
discontinuation of pyrazinamide
platelet count
lesions
sideroblastic anemia with erythroid hyperplasia
vacuolation of erythrocytes
serum iron concentration
alterations in the blood clotting mechanisms
dermatologic side effects
rash
urticaria
pruritus
skin pigmentation
desquamation
photosensitivity
gastrointestinal side effects
nausea
vomiting
anorexia
renal side effects
dysuria
interstitial nephritis
general
side effects
fever
year-old female experienced hypersensitivity hepatitis
pyrazinamide therapy
hospital
fever
nonketotic hyperosmolar syndrome
assessment
diabetes mellitus type
pulmonary tuberculosis
given isoniazid
mg
rifampin
mg
ethambutol
mg
pyrazinamide
mg
month
vomiting
abdominal pain
fever
physical examination
cutaneous jaundice
laboratory tests
elevated alt
u/intl
ast
u/intl
drug-induced hepatitis
day
tuberculosis treatment
patient
rechallenge with the individual tuberculosis drugs
pyrazinamide
patient
acute malaise
fever
arthralgia
perioral paresthesia
vomiting
hours
laboratory tests
elevated ast
u/intl
alt
u/intl
year-old male experienced erythema
pyrazinamide therapy
patient
hospital for a thoracic tuberculosis
cold abscess
isoniazid
mg per day
rifampin
mg per day
ethambutol
mg per day
pyrazinamide
mg per day
days
circinate erythematous maculopapular lesions
bullous lesions
mucous membrane involvement
systemic symptoms
diagnosis of erythema multiforme
biopsy
erythema
discontinuation of the drugs
days
rifampin
pyrazinamide
maculopapular urticarial eruption
regressing
withdrawal of the
drugs
few days
urticaria
single dose of pyrazinamide
leading
definite discontinuation of the drug
hypersensitivity side effects
case of hypersensitivity hepatitis
addition
case of erythema multiforme
side effects of pyrazinamide
fda
healthcare professional for medical advice
pain in large
small joints
loss of appetite
pain
swelling of joints
big toe
ankle
knee
hot skin
affected joints
unusual tiredness
weakness
yellow eyes
skin
itching
skin rash